{
  "ticker": "JNJ",
  "target_date": "2025-10-10",
  "actual_date": "2025-10-10",
  "collected_at": "2025-12-08T12:23:31.204855",
  "price": {
    "open": 190.8,
    "high": 190.86,
    "low": 188.65,
    "close": 189.5167236328125,
    "volume": 9598000,
    "change_1d_pct": -0.19,
    "change_7d_pct": 2.51,
    "change_30d_pct": 8.7
  },
  "technicals": {
    "rsi_14": 95.04,
    "sma_20": 180.98,
    "sma_50": 176.76,
    "macd": 3.992,
    "macd_signal": 3.168,
    "macd_histogram": 0.824,
    "bb_upper": 193.07,
    "bb_lower": 168.89,
    "price_vs_sma20_pct": 4.72,
    "price_vs_sma50_pct": 7.22,
    "volume_ratio": 1.07
  },
  "fundamentals": {
    "market_cap": 487882260480,
    "pe_ratio": 19.546333,
    "forward_pe": 19.103773,
    "price_to_book": 6.146235,
    "price_to_sales": 5.294493,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.56,
    "pct_from_52w_low": 43.94
  },
  "macro": {
    "spy": {
      "price": 653.02,
      "change_1d_pct": -2.7,
      "change_7d_pct": -2.42
    },
    "vix": {
      "level": 21.66,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.05
    },
    "dollar_index": {
      "level": 98.98
    },
    "gold": {
      "price": 3975.9
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Why Protagonist Therapeutics Stock Skyrocketed by Almost 30% Today",
      "source": "Yahoo",
      "datetime": 1760137627,
      "summary": "The company could soon be swallowed by a very large peer -- which also happens to be a business partner.",
      "url": "https://finnhub.io/api/news?id=a71d520ebc122c9607d3c7763d7fa2a14133040fabfaee39d9a09654fe112133"
    },
    {
      "headline": "Q3 Earnings Season Setup Remains Favorable: What to Know",
      "source": "Yahoo",
      "datetime": 1760134560,
      "summary": "The big banks dominate this week's reporting docket, but we also have several bellwethers from other sectors reporting, including Johnson & Johnson, United Air Lines, and others.",
      "url": "https://finnhub.io/api/news?id=5fdff391245cd82e51984d59b6a306a5dfd4d1f704b085895c8018f92a607342"
    },
    {
      "headline": "Johnson & Johnson recommends shareholders reject \"mini-tender\" offer by Tutanota",
      "source": "Yahoo",
      "datetime": 1760127600,
      "summary": "NEW BRUNSWICK, N.J., October 10, 2025--Johnson & Johnson (NYSE: JNJ) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LLC, a limited liability company established pursuant to the laws of the Island of Nevis to purchase up to 500,000 shares of Johnson & John",
      "url": "https://finnhub.io/api/news?id=453c1154ec5eae7c78da3f6c23aabeea012b74ad121a9b4711602ed1fe41562b"
    },
    {
      "headline": "Morgan Stanley Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation",
      "source": "Fintel",
      "datetime": 1760127453,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=928fbb7fcab697500e0f561a667ca9b6e5114bec01b32ad4bb4ba329c8712b8d"
    },
    {
      "headline": "Protagonist Stock Surges on Johnson & Johnson Report",
      "source": "Yahoo",
      "datetime": 1760126003,
      "summary": "Protagonist Therapeutics shares soared 30% Friday after The Wall Street Journal reported that the biopharma company was in talks with Johnson & Johnson about a possible acquistion. See more of the exclusive ...",
      "url": "https://finnhub.io/api/news?id=b6557535e1e3359c145acd6cc48c75fe6f16ebf4270b76ee58b2a32241508cac"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627547.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000196/xslF345X05/wk-form4_1757627547.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627315.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000194/xslF345X05/wk-form4_1757627315.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627206.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000192/xslF345X05/wk-form4_1757627206.xml"
    },
    {
      "form": "8-K",
      "date": "2025-09-09",
      "description": "jnj-20250908.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000190/jnj-20250908.htm"
    },
    {
      "form": "4",
      "date": "2025-09-05",
      "description": "xslF345X05/wk-form4_1757109644.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000186/xslF345X05/wk-form4_1757109644.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}